Spinal disc herniation

Spinal disc herniation, also known as a slipped disc, is a medical condition affecting the spine in which a tear in the outer, fibrous ring of an intervertebral disc allows the soft, central portion to bulge out beyond the damaged outer rings. Disc herniation is usually due to age-related degeneration of the anulus fibrosus, although trauma, lifting injuries, or straining have been implicated. Tears are almost always postero-lateral in nature owing to the presence of the posterior longitudinal ligament in the spinal canal. This tear in the disc ring may result in the release of inflammatory chemical mediators, which may directly cause severe pain, even in the absence of nerve root compression.

Disc herniations are normally a further development of a previously existing disc “protrusion”, a condition in which the outermost layers of the fibrous ring are still intact, but can bulge when the disc is under pressure. In contrast to a herniation, none of the central portion escapes beyond the outer layers. Most minor herniations heal within several weeks. Anti-inflammatory treatments for pain associated with disc herniation, protrusion, bulge, or disc tear are generally effective. Severe herniations may not heal of their own accord and may require surgery. The condition is widely referred to as a slipped disc, but this term is not medically accurate as the spinal discs are firmly attached between the vertebrae and cannot “slip”.

by wikipedia

Biologic Drugs: How They Treat Conditions Like Rheumatoid Arthritis, And How They Stack Up To Synthetics

When we take a trip to the medicine cabinet, chances are most of us are on the hunt for a synthesized, complex compound. Basically, the medications we know and love are mostly made in labs, created through a series of chemical reactions. There are, however, other types of drugs around, even if they’re not as well-known? biologic agents.

These drugs are derived from proteins; and are produced by living organisms like yeast and bacteria, rather than made in a lab. Insulin, for example, is made through a recombinant process and bacteria. Biologic drugs are unfortunately costly to manufacture, but they have a range of skills much different from other, synthetic drugs.

Biologic agents are still used to target disease, but the way it takes action is a bit more complicated than most of its synthesized counterparts. Biologic drugs can replace our body’s proteins (like insulin), disrupt disease processes, or trigger reactions in the body. One example is with conditions like Crohn’s Disease or Rheumatoid arthritis, which cause pain because of inflammation. One way to reduce inflammation is to bind pro-inflammatory cytokines with biologic drugs, keeping the inflammatory cytokines from binding to the cells of the body.

Check out the video to learn more about biologic drugs, including a comparison of these drugs to their synthetic counterparts; and a deeper explanation of expenses.

Ali Venosa / Medical Daily

Parkinson’s disease

Parkinson’s disease (PD), also known as idiopathic or primary parkinsonism, hypokinetic rigid syndrome, or paralysis agitans, is a degenerative disorder of the central nervous system mainly affecting the motor system. The motor symptoms of Parkinson’s disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain. The causes of this cell death are poorly understood. Early in the course of the disease, the most obvious symptoms are movement-related; these include shaking, rigidity, slowness of movement and difficulty with walking and gait. Later, thinking and behavioral problems may arise, with dementia commonly occurring in the advanced stages of the disease, and depression is the most common psychiatric symptom. Other symptoms include sensory, sleep and emotional problems. Parkinson’s disease is more common in older people, with most cases occurring after the age of 50; when it is seen in young adults, it is called young onset PD.

The main motor symptoms are collectively called parkinsonism, or a “parkinsonian syndrome”. The disease can be either primary or secondary. Primary Parkinson’s disease is referred to as idiopathic (having no known cause), although some atypical cases have a genetic origin, while secondary parkinsonism is due to known causes like toxins. Many risks and protective factors have been investigated: the clearest evidence is for an increased risk of PD in people exposed to certain pesticides and a reduced risk in tobacco smokers. The pathology of the disease is characterized by the accumulation of proteins into Lewy bodies in neurons, and insufficient formation and activity of dopamine in certain parts of the midbrain. Where the Lewy bodies are located is often related to the expression and degree of the symptoms of an individual. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used for confirmation.

Treatments, typically the antiparkinson medications L-DOPA and dopamine agonists, improve the early symptoms of the disease. As the disease progresses and dopaminergic neurons continue to be lost, these drugs eventually become ineffective whilst at the same time produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery and deep brain stimulation have been used to reduce motor symptoms as a last resort in severe cases where drugs are ineffective. Research directions include investigations into new animal models of the disease and of the potential usefulness of gene therapy, stem cell transplants and neuroprotective agents. Medications to treat non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, also exist.

In 2013 PD resulted in about 103,000 deaths globally, up from 44,000 deaths in 1990. The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy in 1817. Several major organizations promote research and improvement of quality of life of those with the disease and their families. Public awareness campaigns include Parkinson’s disease day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with parkinsonism who have increased the public’s awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and professional boxer Muhammad Ali.

by wikipedia

Medical Miracle Or Playing God: Human Chimeras Made With Man, Animal Cells Provide New Hope For Organ Transplants

In a world where the demand for organ transplants greatly outnumbers the availability of organ donors, a small division of scientists believes they have a solution: growing human organs inside the bodies of farm animals. Despite the National Institutes of Health (NIH) recently denouncing such projects, some independent U.S. research centers have decided to go ahead with plans to grow humans tissue and organs inside the bodies of genetically altered pigs and sheep.

The complicated process would produce something known as a chimera: an organism with an extra set of DNA that it didn’t inherit from either of its parents. Though they sound like something out of a science-fiction novel, they’re actually a common natural occurrence? they can result from blood transfusions, organ transplants, or in-vitro DNA exchanges between mothers their fetuses. Sometimes they even result from the absorption of one twin in the womb by the other.

With regard to an animal-human chimera, it would be produced from a combination of stem cell technology and gene-editing. Though controversial, the procedure is technically feasible. In a presentation at the NIH’s Maryland campus last November, Dr. Juan Carlos Izpis?a Belmonte of the Salk Institute showed unpublished data from more than a dozen pig embryos that contained human cells. Based on interviews with three U.S. based research teams, the MIT Technology Review estimates about 20 pregnancies involving pig-human or sheep-human chimeras have occurred in the past year. However, none of these animals have gestated to full-term.

In order to create such a creature, scientists must first tweak the DNA inside sheep and pig cells using gene-editing technology, so that the developing embryo will lack certain organs, IFL Science reported. “We can make an animal without a heart,” said Dr. Daniel Garry, a cardiologist who leads a chimera project at the University of Minnesota, according to the MIT Technology Review. “We have engineered pigs that lack skeletal muscles and blood vessels.”

Under normal circumstances, these embryos would not survive without such important organs. But scientists have developed a way to replace the missing cells with stem cells from another species’ embryo in order to grow the missing organ. In 2010, for example, Japanese scientists successfully created mice with pancreases made entirely of rat cells. Breeding sheep and pigs with salvageable human organs would be completely new territory, however.

Though most scientists believe it’s possible, some believe the endeavor poses serious ethical concerns, arguing that it’s unclear if the animal’s human qualities will extend past their organs. “What if the embryo that develops is mostly human?” Pablo Ross, a veterinarian and developmental biologist at the University of California, Davis, told the MIT Tech Review while adding this wasn’t something that he could rule out.

“The specter of an intelligent mouse stuck in a laboratory somewhere screaming ‘I want to get out’ would be very troubling to people,” NIH ethicist David Resnik added during the NIH meeting. Still, the chances of either of these results occurring are unlikely, since only about 0.5 percent of animal-human chimeras’ cells are human.

This past fall, the NIH, one of the world’s foremost medical research centers, announced that it will not fund any study involving human-animal chimeras unless more evidence is presented. But even without NIH funding, the demand for more viable organs for transplant operations, and the sheer curiosity surrounding such a taboo subject, could make human-animal chimeras a reality sooner than you think.

Dana Dovey / Medical Daily

Irritable bowel syndrome

Irritable bowel syndrome (IBS) or spastic colon is a symptom-based diagnosis. It is characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C, or IBS-A, respectively).

As a functional gastrointestinal disorder (FGID), IBS has no known organic cause; however, excessive mast cell activation has a central pathophysiological role in the disorder. IBS is a disorder of the gut?brain axis. Onset of IBS is more likely to occur after infections (postinfectious IBS-PI), or a stressful life event, but varies little with age. For at least some individuals, abnormalities in the gut flora occur, and it has been theorised that these abnormalities result in inflammation and altered bowel function.

A diagnosis of IBS may be made on the basis of symptoms, in the absence of worrisome features such as age of onset greater than 50 years, weight loss, bloody stool, signs of infection or colitis, or family history of inflammatory bowel disease. Routine testing yields no abnormalities, although the bowels may be more sensitive to certain stimuli, such as balloon insufflation testing. Several conditions may present similarly, including coeliac disease, non-celiac gluten sensitivity, fructose malabsorption, mast cell activation disorders, parasitic infections, inflammatory bowel disease, bile acid malabsorption, functional chronic constipation, small intestinal bacterial overgrowth, and chronic functional abdominal pain.

Although no cure for IBS is known, treatments to relieve symptoms exist. This including dietary adjustments, medication, and psychological interventions. Patient education and good doctor?patient relationships are also important. Dietary measures that have been found to be effective include increasing soluble fiber intake. IBS has no direct effect on life expectancy. IBS also does not harm intestines. It is, however, a source of chronic pain, fatigue, and other symptoms, and contributes to work absenteeism. It is common and its effects on quality of life make it a disease with a high social cost. Psychiatric disorders such as anxiety and major depression are common in IBS.

by wikipedia